HPV-based testing and treatment for the elimination of cervical cancer in Papua New Guinea (HPVTATE) [ 7/1/2021 - 6/30/2025 ]

Research Grant

Brief description Building on the innovative cervical screening model that we successfully designed and delivered in partnership with provincial health authorities in urban primary care settings in PNG, the overarching aim of the proposed study is to determine the reach, effectiveness, cost-effectiveness, acceptability and scalability of HPV-based testing and treatment for the elimination of cervical cancer (HPVTATE) among women in rural and remote communities in Papua New Guinea.

Funding Amount $1,590,167

Funding Scheme International Collaborations

Chief Investigator Prof Andrew Vallely

Notes GACD Cancer Prevention Call funding commencing 2021